Cannabis genetics in low-earth orbit. Flight heritage, not concept work.
Applied research and controlled-environment infrastructure for extreme operating environments — anchored by a low-earth-orbit cultivation programme conducted in partnership with Genesis Space Flight Laboratories. Summer 2025 marked the first cannabis genetics ever launched into space, carried aboard a SpaceX Falcon 9. The mission gives the Group's frontier-science vertical real flight heritage and sets the operating template for future LEO-resident genetic preservation and controlled-environment research.
Summer 2025 — first cannabis genetics in space.
In summer 2025 the Group placed the first cannabis genetics ever flown into low-earth orbit, carried aboard a SpaceX Falcon 9 under a research mission conducted in partnership with Genesis Space Flight Laboratories. The flight is a documented milestone for the cannabis sector and the operating anchor for the Group's frontier-science vertical.
The mission profile is deliberately applied: characterise cultivar response to microgravity, radiation, and sealed-environment exposure; preserve selected lines under LEO-resident conditions; and feed the resulting data back into the Group's terrestrial cultivation IP and genetic-preservation library. Research outputs are routed into operating brands and partner programmes — not packaged as marketing claims.
Flight payloads — tissue culture, seeds, and propagated plants — are returned to Earth and held in the Group's terrestrial research facilities for a five-year longitudinal study following each mission. Genotype, phenotype, vigour, and second-generation expression are tracked against pre-flight baselines and against cohorts from prior flights, so each mission compounds the dataset for the next. The programme is built toward a clear horizon: the cultivar libraries, sealed-environment protocols, and preservation discipline needed for lunar and Mars cultivation, under the same standards the Group applies to its terrestrial production.
"Flight heritage, not concept work. The first cannabis genetics in space — Summer 2025, SpaceX Falcon 9, in partnership with Genesis Space Flight Laboratories. Five-year ground study per mission. Horizon: lunar and Mars."
Where regulated cultivation meets frontier infrastructure.
The frontier-science vertical extends the same disciplines that anchor the Group's cannabis and pharma verticals — standardised cultivation protocols, genetic-IP capability, GMP-aligned production discipline, and compliance-grade documentation — into adjacent applied-research domains where the operating environment is extreme or sealed.
Activity is structured around controlled-environment systems, genetic preservation libraries, advanced agritech research programmes, and the LEO cultivation work conducted with Genesis Space Flight Laboratories. The Group's position is deliberately applied rather than speculative.
Where the frontier-science platform applies.
Controlled-environment agriculture
Precision greenhouse design, closed-loop organic systems, and sealed-environment production protocols — extending the Group's 30+ years of cultivation discipline into research environments where atmosphere, water, light, and microbiome are fully controlled.
Genetic preservation
Long-horizon preservation of cultivar lineage, seed-bank discipline, and genetic-IP custody — supported by the same provenance and authentication infrastructure used across MetaFlora and BloomBridge Ledger.
Low-earth-orbit research
LEO cultivation work conducted in partnership with Genesis Space Flight Laboratories. The Summer 2025 Falcon 9 mission carried the first cannabis genetics into space. Tissue culture, seeds, and propagated plants are returned to the Group's terrestrial facilities and studied for five years per mission, so each flight compounds the cultivar dataset for the next — with sights set on lunar and Mars cultivation.
Applied research mandate
Research conducted through BloomBridge Space and Advanced Agritech, with Genesis Space Flight Laboratories as flight partner, is mandate-driven — not blue-sky. Outputs are designed to be deployed back into the Group's regulated operating environments.
Frontier infrastructure
Infrastructure relevant to extreme operating environments — sealed cultivation, remote sensing, and resilience-grade systems for jurisdictions and theatres where conventional supply chains do not reach.
Advanced materials
Adjacent advanced-materials research aligned with the Group's controlled-environment and preservation programs, conducted under partner arrangements where source material and counterparties are appropriate.
Cross-vertical alignment
The frontier-science vertical is the Group's long-horizon counterpart to its operating brands — feeding back into cultivation IP, ledger infrastructure, and pharma research with disciplines that compound across the rest of the Group.
Operating brands within the vertical.
Research and partner access to the frontier-science vertical.
Research partnerships, applied-program briefings, and controlled-environment engagements issued under NDA. Routed through the Group's Medical & Research Board where clinical relevance applies.